Supernus Pharmaceuticals
SUPN
#4399
Rank
โ‚น157.83 B
Marketcap
โ‚น2,828
Share price
1.07%
Change (1 day)
3.29%
Change (1 year)

Revenue for Supernus Pharmaceuticals (SUPN)

Revenue in 2024 (TTM): โ‚น55.65 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น56.62 Billion. an increase over the revenue in the year 2023 that were of โ‚น50.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Supernus Pharmaceuticals from 2011 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น56.77 B12.26%
2023 โ‚น50.57 B-8.4%
2022 โ‚น55.21 B27.95%
2021 โ‚น43.15 B13.39%
2020 โ‚น38.05 B35.89%
2019 โ‚น28.00 B-2.04%
2018 โ‚น28.59 B48.15%
2017 โ‚น19.29 B32.08%
2016 โ‚น14.61 B50.14%
2015 โ‚น9.73 B66.45%
2014 โ‚น5.84 B687.27%
2013 โ‚น0.74 B817.01%
2012 โ‚น80.97 M-116.85%
2011 -โ‚น0.49 Billion

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น6.98 B-87.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น246.19 B 334.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.853 T 6,705.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.132 T 7,198.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.589 T 6,238.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.599 T 13,320.78%๐Ÿ‡บ๐Ÿ‡ธ USA